In April 2024, the Centers for Medicare & Medicaid Services (CMS) announced the upcoming rate changes expected for Medicare Advantage (MA) and Medicare Part D Prescription Drug Plans (Part D) for Calendar Year (CY) 2025.
Let’s take a closer look at how Part D will change in 2025. In 2025, the four phases of Part D will now be condensed into three phases.
1. Annual deductible
During this phase, you’re responsible for the full price of a prescription drug. Deductible amounts change according to the plan. Some plans have no deductible. The out-of-pocket costs will be lower and capped at $2,000.
2. Initial coverage
The Coverage Gap Discount Program (CGDP) from 2024 will be phased out and replaced by the new manufacturer’s discount program. There are also new changes to the liability of enrollees, Part D sponsors, manufacturers, and CMS in the newly defined standard Part D benefit design.
Once you’ve met your deductible amount, a plan will cover some of your prescription drug costs. The length of this phase depends on your plan and drug costs.
3. Catastrophic coverage
The way catastrophic coverage works has changed every year since 2023. In 2025, the catastrophic coverage phase applies when you reach $8,000 in out-of-pocket costs for prescription drugs. There are specific costs that qualify. For instance, monthly premiums aren’t costs that count towards $8,000. Your exact out-of-pocket contribution to reach $8,000 depends on your plan’s benefit design and the mix of brand name and generic drugs you take.
4. Lower costs
With the Inflation Reduction Act, those with Part D drug plans can expect to see potentially more savings and lower costs for prescription drugs. The Final CY 2025 Part D redesign is a result of President Biden’s legislation to keep drugs costs in line.
It’s important to note that insulin is still uniquely priced at $35/month per covered prescription as it was in 2024.